Back to Journals » Drug Design, Development and Therapy » Volume 14

Clinical Trial Report

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers

       
Total article views   HTML views PDF downloads Totals
6,468 Dovepress* 5,899+ 802 6,701
PubMed Central* 569 166 735
Totals 6,468 968 7,436
*Since 5 August 2020

View citations on PubMed and Google Scholar